Edwards Lifesciences
1,315 hedge funds and large institutions have $66.5B invested in Edwards Lifesciences in 2021 Q4 according to their latest regulatory filings, with 207 funds opening new positions, 459 increasing their positions, 415 reducing their positions, and 94 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
8% more funds holding
Funds holding: 1,221 → 1,315 (+94)
5% more call options, than puts
Call options by funds: $250M | Put options by funds: $239M
0.11% more ownership
Funds ownership: 82.34% → 82.45% (+0.11%)
Holders
1,315
Holding in Top 10
27
Calls
$250M
Puts
$239M
Top Buyers
| 1 | +$519M | |
| 2 | +$330M | |
| 3 | +$285M | |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
+$199M |
| 5 |
Capital International Investors
Los Angeles,
California
|
+$162M |
Top Sellers
| 1 | -$636M | |
| 2 | -$364M | |
| 3 | -$261M | |
| 4 |
JSP
Jackson Square Partners
Larkspur,
California
|
-$147M |
| 5 |
OCBV
Ownership Capital B.V.
Amsterdam,
Netherlands
|
-$129M |